MSDH Launches Webpage with Information on Early Medical Marijuana Program | Mississippi Politics and Current Affairs
The Mississippi State Department of Health began working to meet the legal requirements of the Mississippi Legislature to establish the state’s medical marijuana program.
Mississippi Medical Cannabis Program
Since its passage, the MSDH has launched part of the medical marijuana program on its website outlining what is planned to come.
The top of the page says:
“The Mississippi State Department of Health is committed to complying with the legal requirements of the Mississippi Medical Cannabis Act recently enacted by the Mississippi Legislature and signed by Governor Tate Reeves. Our goal is to provide a safe and accessible program that meets patient needs and the public health and safety of all Mississippi residents.
Under legislation passed in M, MSDH has 120 days to begin accepting applications for different aspects of the program. Their website states that by June 2022 they will have online license applications for patients, physicians, cannabis grow facilities, treatment facilities, testing facilities, waste disposal entities and transport entities.
Once a request is submitted, that person or business will receive a response within 30 days, five days for patients.
Business registration must first take place through the office of the Secretary of State.
The site also clarifies the eligibility requirements for those interested in participating.
- Parkinson’s disease
- Huntington’s disease
- muscular dystrophy
- spastic quadriplegia
- positive status for human immunodeficiency virus (HIV)
- acquired immunodeficiency syndrome (AIDS)
- amyotrophic lateral sclerosis (ALS)
- Crohn’s disease
- ulcerative colitis
- sickle cell anemia
- Alzheimer’s disease
- dementia agitation
- post-traumatic stress disorder (PTSD)
- pain refractory to appropriate opioid management
- diabetic/peripheral neuropathy
- spinal cord disease or serious injury
Also eligible is a terminal or debilitating chronic disease or medical condition or its treatment that produces one or more of the following:
- cachexia or wasting syndrome
- chronic pain
- severe or intractable nausea
- severe and persistent muscle spasms, including but not limited to those characteristic of multiple sclerosis